Bazedoxifene Acetate Tablets 20mg (Bazedoxifene Tablets “Sawai”® / バゼドキシフェン錠20mg「サワイ」)

JPY ¥2,827

Japanese Osteoporosis Treatment Agent (Bazedoxifene Acetate 20mg). Oral film-coated tablet for postmenopausal osteoporosis, once daily. 100 tablets (10 tablets x 10). Mfd. by Sawai Pharmaceutical Co., Ltd., Japan.

SKU: BAZ-20-TAB Category:

Description

Product Overview / 商品概要

Bazedoxifene Tablets 20mg “Sawai” (バゼドキシフェン錠20mg「サワイ」)
Generic: Bazedoxifene Acetate / バゼドキシフェン酢酸塩
Therapeutic Category: Osteoporosis Treatment Agent / 骨粗鬆症治療剤
Manufactured by: Sawai Pharmaceutical Co., Ltd. / 沢井製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Bazedoxifene Acetate 22.6mg (equivalent to Bazedoxifene 20mg) per tablet / 1錠中 バゼドキシフェン酢酸塩 22.6mg(バゼドキシフェンとして20mg)
Additives: Ascorbic acid, Carnauba wax, Light anhydrous silicic acid, Microcrystalline cellulose, Titanium oxide, Ferric oxide, Magnesium stearate, Talc, Sodium starch glycolate, Lactose, Hydroxypropylcellulose, Hypromellose, Partially pregelatinized starch, Macrogol 6000, Sodium lauryl sulfate / アスコルビン酸、カルナウバロウ、軽質無水ケイ酸、結晶セルロース、酸化チタン、三二酸化鉄、ステアリン酸Mg、タルク、デンプングリコール酸Na、乳糖、ヒドロキシプロピルセルロース、ヒプロメロース、部分アルファー化デンプン、マクロゴール6000、ラウリル硫酸Na
Appearance: Film-coated tablet; pale yellow; dimensions 11.2 x 6.2mm; thickness 5.0mm; weight approx. 310mg; imprint: Bazedoxifene 20 Sawai
外観: 剤形: フィルムコーティング錠、性状: 淡黄色、直径: 11.2×6.2mm、厚さ: 5.0mm、重量: 約310mg、本体表示: バゼドキシフェン 20 サワイ

Indications / 効能効果

EN: Postmenopausal osteoporosis
JA: 閉経後骨粗鬆症

Dosage and Administration / 用法用量

EN: The usual dose is 20mg of bazedoxifene administered orally once daily.
JA: 通常、バゼドキシフェンとして、1日1回20mgを経口投与する。

Contraindications / 禁忌

EN: 2.1 Patients with or with a history of venous thromboembolism (e.g., deep vein thrombosis, pulmonary embolism, retinal vein thrombosis) / 2.2 Patients in prolonged immobile states (e.g., postoperative recovery, prolonged bed rest) / 2.3 Patients with antiphospholipid antibody syndrome / 2.4 Pregnant women, women who may be pregnant, or breastfeeding women / 2.5 Patients with a history of hypersensitivity to any component of this product
JA: 2.1 深部静脈血栓症、肺塞栓症、網膜静脈血栓症等の静脈血栓塞栓症のある患者又はその既往歴のある患者 / 2.2 長期不動状態(術後回復期、長期安静期等)にある患者 / 2.3 抗リン脂質抗体症候群の患者 / 2.4 妊婦又は妊娠している可能性のある女性及び授乳婦 / 2.5 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 30200AMX00062000
Sales Started: September 2020 / 2020年9月
Classification Code: 873999
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets (10 tablets x 10) / 100錠(10錠×10)
Other Available Packages (by special order): PTP: 100 tablets (10 tablets x 10), 140 tablets (14 tablets x 10), 500 tablets (10 tablets x 50)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Bazedoxifene Acetate Tablets 20mg (Bazedoxifene Tablets “Sawai”® / バゼドキシフェン錠20mg「サワイ」)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Bazedoxifene Acetate Tablets 20mg (Bazedoxifene Tablets "Sawai"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.